The Sleep Apnea Devices Market reached US$5.1 billion at the end of 2018 and is set to stride over US$8.83 Billion at the end of 2026, with a CAGR of 7.1%.
With more than one billion people suffering from sleep apnea, it has become one of the major disorders in recent times. Sleep Apnea is a potential sleep disorder characterized by the repeated intermittent block of breathing during sleep for a few seconds. Three types of sleep apnea are reported namely obstructive, central and mixed. Of which, Obstructive Sleep Apnea (OSA) is the common type resulting from airway obstruction due to which the breathing is blocked for at least ten seconds.
In 2007, the World Health Organization (WHO) estimated the OSA to be over 100 million, but the numbers have significantly increased in recent times. In the US, sleep apnea is considered one of the major disorders where the average sleeping hours during night time is not more than 6 hours. Approximately 22.5% of women and more than 45% of men suffer from sleep apnea problems wherein 1 in 12 individuals report for obstructive sleep apnea. The prevalence of OSA occurs in about 26% of the adult population between 30 and 65 years and around 2-4% of the children aged 2-8 years. OSA also increases the occurrence of cardiac co-morbidities including heart failure by more than 100%, stroke by more than 50% and CAD by more than 25%. Also, there are high chances of developing psychological comorbidities such as anxiety, depression, bipolar disorders, etc.
With increase in the geriatric population prevalent with sleep apnea, diseases which can lead to development of Sleep Apnea such as stroke, hypertension, diabetes, obesity, stress, etc., rising awareness among the patients, development of healthcare infrastructure for advanced treatment methodologies, is set to drive the Sleep Apnea Market in the forthcoming years. Yet, patient discomfort while using sleep apnea devices and the competitiveness of the market comprising of several advanced devices can hamper the market growth.
The Sleep Apnea diagnosis market is growing along with the treatment market which comprises of actigraphs, pulse oximeters, respiratory polygraphs, polysomnography, etc. The polysomnography devices occupied a market share of more than 34% in the year 2018 and are said to contribute to growth with a CAGR of around 6.78% during the forecast period. This is because, polysomnography is one of the most trusted and preferred methodologies for detecting sleep apnea, especially the apnea-hypopnea index (AHI). Besides, the respiratory polygraph devices market is set to expand at a CAGR of 7.2% where these devices are primarily used in the screening of sleep apnea in homes similar to polysomnography used in clinics and hospitals. Respiratory polygraph is one of the preferred methods by patients due to its cost-effectiveness. This is set to drive the overall sleep apnea diagnostic market to grow at a CAGR of 6.49% between 2019 and 2026.
Positive Airways Pressure (PAP) devices are the standard treatment availed by many people worldwide. These devices are mainly prescribed for OSA but can be used for central sleep apnea treatment as well. The device pushes air through the nasal routes through the airway passage at a high pressure preventing the occurrence of apnea during sleep. This enables normal sleep for individuals suffering from sleep apnea and also reduces the risks of developing comorbidities associated with sleep apnea. In recent times, sleep apnea devices are miniaturized to make it comfortable for patients to carry wherever they travel. This level of advancement is promoting sleep apnea devices for treatment and is also propelling market growth.
The North American region ruled the market with over 50% of the market share followed by the European market with around 35% with Asia-Pacific and LAMEA contributing to nearly 12% of the total market share. The tremendous growth in the North American region can be attributed to technological advancement which is enabling the researchers to conduct more sleep tests to identify and diagnose the patients suffering from sleep apnea. Also, the awareness among the population regarding the sleep apnea had surged leaps and bounds. In the European market, especially Germany and France are said to contribute more towards the market growth as the awareness among people regarding the treatment available is more. Further, the reimbursement policies are also aiding market growth in the region.
In the Asia-Pacific region, the market remains mostly untapped as a greater number of individuals suffering from the condition remain undiagnosed and unaware of the condition. Lack of awareness and lack of technological development are also the reason why this market is still in its nascent stages. However, the penetration of companies across the Asian market is eventful in recent periods which is becoming a lucrative region for investment. Also, government policies support the manufacturing and pharma companies to strengthen their presence. The growing population, increase in the number of clinics, rising health care expenditure, etc. expected to contribute to robust growth in the Asia-Pacific region in the forecast period between 2019-2026.
The Sleep Apnea market is segmented based on therapies, product types, regions, end-user, and epidemiology. The Sleep Apnea Devices Market Outlook 2019-2026, from Optima Insights, will offer a thorough insight on the market growth till the forecast year 2026 based on the market segmentation (Epidemiology, Therapies, Disorder Type, End-user and Region). The report comprises comprehensive profiling of companies involved in treatment devices and products under development for sleep apnea.
There are 17 Key Major Players including Philips Respironics, Resmed, Medtronic, Resonea, Apex Medical, Itamar Medical Ltd., Respicardia, Inc, Invacare Corporation and many more. Also, 14 companies are classified under the category of New Market Entrants and Emerging Companies. With stringent regulations for sleep apnea devices manufacturing, the new barrier has risen for the companies for increasing their geographical presence and also handle the competition within the market.
Key Developments
June 2019: The study published in CHEST Journal suggests that CPAP-treated sleep apnea may be linked to a reduction in the risk of diabetes
June 2019: Israeli’s Itamar Medical’s FDA-cleared WatchPAT, to integrate sleep apnea management into the cardiac patient care pathway
June 2019: Signifier Medical Technologies closes Series 2 funding round for continued development of daytime neurostimulator for snoring, mild sleep apnea
The Report Provides Key Insights on
- History of the Sleep Apnea Devices Market, 2015 to 2017
- Forecast of the Sleep Apnea Devices Market Growth till the year 2026
- The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Sleep Apnea Devices Market
- Analysis of potential growth segments which will drive the market
- Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market
- Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics
Sleep Apnea Devices Market Based on Epidemiological Assessment (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
- Adherence Assessment
- Prescription Pattern Assessment
- Epidemiological Assessment
Sleep Apnea Devices Market Based on Alternate Therapies (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
- Positional Therapy
- Oral Pressure Therapy
- Hypoglossal Nerve Stimulation
- Expiratory Positive Airway Pressure
Sleep Apnea Devices Market Based on Type (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
- Diagnostic Devices
- Sleep Screening Devices
- Oximeters
- Actigraphy Systems
- Home Sleep Testing Devices
- Polysomnography Devices
- Therapeutic Devices
Sleep Apnea Devices Market Based on End-User (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
- Home Care Settings
- Sleep Laboratories & Hospitals
Sleep Apnea Devices Market Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
- North America
- Europe
- APAC
- LAMEA
Sleep Apnea Devices Market Competitive Analysis (Company Overview, SWOT Matrix, Financial, Product Overview, and Market Strategies)
- Natus Medical Incorporated
- Nihon Kohden Corporation
- Fisher & Paykel Healthcare Limited
- Apex Medical
- Invacare Corporation
- Philips Respironics
- Respicardia, Inc.
- Vyaire Medical
About Us
Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.
Contact
Optima Insights
Chaucks G
+91 966 6620 365 (Asia) | +1 424 2554 365 (US)
Email: sales@optimainsights.org
https://www.optimainsights.org
